Rivia

📍 Zurich, Switzerland🗓 Founded 2022👥 23 employees💰 Last funded Mar 2026
Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global clinical trials on Rivia have demonstrated measurable impact, from earlier understanding of therapeutic potential to significantly more efficient trial execution. In the years ahead, the company will scale its platform and embedded intelligence to help bring groundbreaking therapies to market faster. Learn more at https://rivia.com
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Rivia?
Rivia has 1 investors on record on gritt.io, 1 mid-stage.
When did Rivia last raise funding?
The most recent investment in Rivia recorded on gritt.io was in March 2026.
When was Rivia founded?
Rivia was founded in 2022.
What industry is Rivia in?
Rivia operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Rivia based?
Rivia is headquartered in Zurich, Switzerland.